David Dunn

Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.

M. Ohlmeyer, Peter Littlewood, J. Maclean, 2011, Bioorganic & medicinal chemistry letters.

Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.

M. Ohlmeyer, J. Maclean, Koc-Kan Ho, 2011, Bioorganic & medicinal chemistry letters.

Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat model.

Yajing Rong, A. Klon, M. Webb, 2009, Bioorganic & medicinal chemistry letters.